Sale!

RNF170 Gene Ataxia Sensory Type 1 Autosomal Dominant Genetic Test

4,400 د.إ

-21%

The RNF170 Gene Ataxia Sensory Type 1 Autosomal Dominant Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the RNF170 gene, which are associated with a rare form of ataxia known as Sensory Type 1 Autosomal Dominant Ataxia. This condition primarily affects the nervous system, leading to issues with movement, coordination, and sometimes sensory functions. The test is particularly crucial for individuals showing symptoms of the disorder or those with a family history of ataxia, as it can confirm the diagnosis and facilitate appropriate management and treatment strategies.

Performed at DNA Labs UAE, a leading facility in genetic testing, the test ensures accuracy and reliability in results. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis involved in identifying the genetic mutation responsible for the condition. By opting for this test, patients and their families can gain valuable insights into their genetic health, enabling informed decisions about their medical care and lifestyle adjustments to accommodate the condition. DNA Labs UAE employs state-of-the-art technology and follows stringent protocols to ensure the confidentiality and safety of the patient’s genetic information.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

RNF170 Gene Ataxia Sensory Type 1 Autosomal Dominant Genetic Test

Welcome to DNA Labs UAE, where we offer the RNF170 Gene Ataxia Sensory Type 1 Autosomal Dominant Genetic Test. This test is designed to identify mutations in the RNF170 gene associated with ataxia, sensory type 1, an autosomal dominant genetic disorder that affects the nervous system.

Test Components

The RNF170 Gene Ataxia Sensory Type 1 Autosomal Dominant Genetic Test includes:

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Before undergoing the RNF170 Gene Ataxia Sensory Type 1 Autosomal Dominant Genetic Test, it is important to provide the following:

  • Clinical History of the Patient
  • A Genetic Counselling session to draw a pedigree chart of family members affected with RNF170 Gene Ataxia, sensory type 1, autosomal dominant

Test Details

The RNF170 gene is associated with ataxia, sensory type 1, an autosomal dominant genetic disorder that affects the nervous system. Symptoms of this disorder may include difficulty with balance and coordination, numbness or tingling in the hands and feet, muscle weakness, and difficulty speaking or swallowing.

NGS genetic testing is used to identify mutations in the RNF170 gene. This involves sequencing the DNA of the patient to look for changes in the gene that may be causing the disorder. If a mutation is found, it can help confirm a diagnosis and provide information about the likely progression of the disease.

Knowing the genetic cause of ataxia, sensory type 1 can also be helpful for family members who may be at risk of inheriting the disorder. Genetic counseling can provide information about the risks and options for testing and management.

Test Name RNF170 Gene Ataxia sensory type 1 autosomal dominant Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for RNF170 Gene Ataxia, sensory type 1, autosomal dominant NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with RNF170 Gene Ataxia, sensory type 1, autosomal dominant
Test Details

The RNF170 gene is associated with ataxia, sensory type 1, autosomal dominant. This is a genetic disorder that affects the nervous system and causes problems with movement and sensation. Symptoms may include difficulty with balance and coordination, numbness or tingling in the hands and feet, muscle weakness, and difficulty speaking or swallowing.

NGS genetic testing can be used to identify mutations in the RNF170 gene. This test involves sequencing the DNA of the patient to look for changes in the gene that may be causing the disorder. If a mutation is found, it can help to confirm a diagnosis and provide information about the likely progression of the disease.

Knowing the genetic cause of ataxia, sensory type 1 can also be helpful for family members who may be at risk of inheriting the disorder. Genetic counseling can provide information about the risks and options for testing and management.